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We present a mathematical model for the concentrations of proangiogenic and antiangiogenic growth factors, and their resulting
balance/imbalance, in host and tumor tissue. In addition to production, diﬀusion, and degradation of these angiogenic growth
factors (AGFs), we include interstitial convection to study the locally destabilizing eﬀects of interstitial ﬂuid pressure (IFP) on the
activity of these factors. The molecular sizes of representative AGFs and the outward ﬂow of interstitial ﬂuid in tumors suggest that
convection is a signiﬁcant mode of transport for these molecules. The results of our modeling approach suggest that changes in
the physiological parameters that determine interstitial ﬂuid pressure have as profound an impact on tumor angiogenesis as those
parameters controlling production, diﬀusion, and degradation of AGFs. This model has predictive potential for determining the
angiogenic behavior of solid tumors and the eﬀects of cytotoxic and antiangiogenic therapies on tumor angiogenesis.
1.Introduction
The process of angiogenesis, the development of new blood
vessels from preexisting vasculature, is governed by the net
balance between proangiogenic and antiangiogenic growth
factors [1]. Multiple regulatory factors are involved in this
process, including the vascular endothelial growth factor
(VEGF) family and its receptors, the ﬁbroblast growth factor
(FGF) family, angiostatin, and endostatin [1]. During tumor
progression, this delicate balance is skewed in favor of
angiogenesis, resulting in an abnormal tumor vasculature
and microenvironment [2, 3].
The tumor vascular network is spatially and temporally
heterogeneous, and hypoxia, acidosis, and elevated intersti-
tial ﬂuid pressure (IFP) are characteristic features of solid
tumors. While it is known that all three of these traits play
critical roles in the activity and upregulation of angiogenic
growth factors (AGFs), the relationships between these fea-
tures and tumor angiogenesis are complex and not fully
understood. The most prominent and widely studied AGF
is VEGF, a potent proangiogenic agent that is indepen-
dently upregulated by both hypoxia and acidosis [4]. While
angiogenesis is commonly triggered as a result of hypoxia,
it is also the case that acidic pH induces several angiogenic
molecules such as basic FGF [5] and nitric oxide [6]. Al-
though the eﬀects of hypoxia and acidosis on angiogenic
factors have been investigated experimentally, the eﬀects of
elevated IFP are less clearly understood. Here, we seek to
exploretheeﬀectofIFPgradientsonproangiogenicandanti-
angiogenicfactorconcentrations,withafocusontheangiog-
enic tendency induced by their imbalance.
Two compounding factors that contribute to elevated
IFP in solid tumors are the increased permeability of blood
vessels and the absence of functional lymphatics [3, 7]. It has
been hypothesized that the normalization of tumor vessels,
by the application of antiangiogenic therapies such as anti-
bodies inhibiting VEGF or blocking VEGFR-2, would lead
to lowered tumor IFP [2, 8]. Baxter and Jain [9] developed
a mathematical model to study the transport of ﬂuid and
macromolecules in tumors. Recently, Jain et al. [10] revisited
theirmodeltoinvestigatetheeﬀectofvascularnormalization
by antiangiogenic therapy on IFP, as well as to determine the
parameters that could lead to a reduction of IFP.2 Computational and Mathematical Methods in Medicine
Table 1: Molecular weights of common proangiogenic and antian-
giogenic growth factors.
Molecule Angiogenic category Size (kDa)
VEGF165 dimer Proangiogenic 45 [13]
FGF family Proangiogenic 17–34 [14]
TSP-1 Antiangiogenic 140 [15]
Angiostatin Antiangiogenic 38 [16]
Endostatin Antiangiogenic 20 [17]
In other work, Ramanujan et al. [11] used a mathemat-
ical framework to study the local imbalance of pro- and
antiangiogenic factors. Their model contained production,
diﬀusion, and degradation of these factors, and was used to
explain focal necrosis and dormancy in tumors. Here, we
generalize their model and include the eﬀect of interstitial
convection on proangiogenic and antiangiogenic factor con-
centrations, which is supported by the fact that convection
can contribute signiﬁcantly to the transport of molecules
of the typical size of AGFs (see Table 1). It has also been
noted that convection plays an important role, not only
in determining local concentrations, but also in the func-
tionality and activity of AGFs, particularly VEGF [12]. This
eﬀect is added via a convection term in the equations that
govern the concentrations of AGFs (see following section).
The mathematical model is then used to study the changes in
a tumor’s angiogenic behavior as a result of altering tissue or
blood vesselproperties (e.g.,hydraulicconductivityof tissue,
hydraulic permeability of vessels).
2.MaterialsandMethods
2.1. Angiogenic Growth Factor Model. Following Hahnfeldt
et al. [18], and Ramanujan et al. [11], we ﬁrst assume that
angiogenic growth factors can be considered to initiate either
proangiogenic (stimulatory) or antiangiogenic (inhibitory)
activity. Although some of these factors may behave in
either a proangiogenic or antiangiogenic manner depending
on the state of the system, we consider this eﬀect to be
negligible. Whilediﬀerentcellularmechanisms andsignaling
cascades activated by speciﬁc (and possibly multiple) factors
have greater eﬀects on the level of angiogenic activity than
others,wesimplyconsiderthepro-andantiangiogenicfactor
concentrations to be representative of the angiogenic eﬀect
enabled by these two categories. The proangiogenic (p)a n d
antiangiogenic (a) factor concentrations will be denoted by
fp and fa (μg/mm3), respectively. These factors are assumed
to diﬀuse with constant diﬀusion coeﬃcients Dj (mm2/s),
j = p,a, to degrade under ﬁrst-order kinetics with constant
deactivation rates kj (s−1) and to be produced indepen-
dently with constant production rates gj (μg/mm3/s). Since
the aforementioned diﬀusion, deactivation, and production
parameters are used to describe entire families of factors
with varying molecular weights and kinetic rates, they are
assumed to be representative of their respective angiogenic
categories. However, each of these parameters can diﬀer in
host and tumor tissue, both of which are assumed to be
homogeneous and isotropic, so that when appropriate, we
will distinguish between these values with superscripts for
host (h)a n dt u m o r( t) tissues. As indicated earlier, we also
include the convection of these factors since interstitial ﬂuid
velocity (IFV) in the tumor plays a role in determining
the concentration of macromolecules including AGFs in the
tumor. Assuming the velocity of these molecules is equal to
the interstitial ﬂuid velocity u (mm/s) [19], we arrive at the
equation
∂fj
∂t
= Dj∇2 fj −kj fj +gj −∇·
 
ufj
 
, j = p,a,( 1 )
where the IFV is given by Darcy’s law: u =− K∇p,w h e r eK
(mm2/s/mmHg) is the hydraulic conductivity of the inter-
stitium and p (mmHg) is the IFP [20, 21]. The equations
governing IFP are derived below and presented in (5). By
adding convection to this equation, we can study larger
tumors since the model was previously restricted to those
whereconvectionwasnotafactor(usuallythosetumorswith
radii less than 2mm). It is worthwhile reemphasizing that
interstitial convection also plays a vital role in the activity of
AGFsandtheprocessoftumorangiogenesis[12].Convective
eﬀects have been incorporated in previous models of drug
distribution and other macromolecules in tumors [9, 20],
and thus it seems natural to include it in this case. The
parameters for the diﬀusion, production, and degradation of
AGFs inside the host and tumor tissues are those assumed
based on the conditions stated in Ramanujan et al. [11]a n d
these are presented in Table 2.
To facilitate solving (1), we assume that the tumor is a
sphere of radius R (mm), and since the dynamics of growth
factor distribution occur on a much faster time scale than
tumor growth, we consider the system in steady state. This
results in the equation
Dj
r2
d
dr
 
r2dfj
dr
 
−kj fj +gj +
K
r2
d
dr
 
r2dp
dr
fj
 
= 0. (2)
Equation (2) can be nondimensionalized by setting   r = r/R
and   fj = fj/fs
j where f s
j = gh
j /kh
j is the steady-state AGF
concentration in host tissue. Dividing by Dj eliminates the
diﬀusion coeﬃcient and gives the nondimensional param-
eters   kj = kjR2/Dj,   gj = gjR2/(Dj f s
j ) and,   Kj = Kp e/Dj
where pe (mmHg) is the eﬀective pressure used to nondi-
mensionalize the equation for pressure (the nondimensional
pressure is deﬁned to be   p = p/pe,r e f e rt o( 6)). This non-
dimensionalization yields the equation
1
  r2
d
d  r
⎛
⎝  r2d   fj
d  r
⎞
⎠ −   kj   fj +   gj +
  Kj
  r2
d
d  r
 
  r2d  p
d  r
  fj
 
= 0. (3)
This step is essential to the model since the nondimensional
quantities are used to deﬁne a measure of angiogenic activity
below in (4).
Intheabsenceoftheconvectionterm,thatis,eliminating
the last term in (3), an analytical solution can be obtained
with appropriate boundary conditions [11]. However, in this
work, we also consider the scenario where diﬀusion andComputational and Mathematical Methods in Medicine 3
Table 2: Model parameters [10, 11].
Parameter Units Host Tumor Normalized
R mm — 4 4
K mm2/s/mm Hg 2.5 × 10−5 2.5 × 10−5 2.5 × 10−5
Angiogenic growth factors
Dp mm2/s 4.0 × 10−5 5.5 × 10−5 5.5 × 10−5
Da mm2/s 3.25 × 10−5 4.0 × 10−5 4.0 × 10−5
kp s−1 2.0 × 10−4 1.99 × 10−4 1.99 × 10−4
ka s−1 1.5 × 10−4 1.1 × 10−4 1.1 × 10−4
gp μg/mm3/s 2.0 × 10−4 12.0 × 10−4 12.0 × 10−4
ga μg/mm3/s 1.5 × 10−4 7.0 × 10−4 7.0 × 10−4
  kp — 80 57.9 57.9
  ka — 73.8 44 44
  gp — 80 349 349
  ga — 73.8 280 280
  Kp — 12.5 9.1 9.1
  Ka — 15.4 12.5 12.5
Interstitial ﬂuid pressure
Lp mm/s/mmHg 3.6 × 10−7 1.86 × 10−5 3.7 × 10−6
S/V mm2/mm3 17.4 16.5 15.2
pv mmHg 20 20 20
σ — 0.91 8.7 × 10−5 2.1 × 10−3
πv mmHg 20 19.8 19.2
πi mmHg 10 17.3 15.1
pe mmHg 10.9 20 20
α —2 1 4 6
convection could play a signiﬁcant role in factor transport,
and hence we rely on numerical integration schemes to solve
(3).
2.2. Angiogenic Activity. While we are interested in the
qualitative eﬀects of IFP on AGF concentrations, we are not
speciﬁcally interested in the quantitative concentrations of
thesetwofactorgroups.Therelationshipbetweentheproan-
giogenic and antiangiogenic forces is of greater importance,
since the balance between these factors is the determinant of
whether angiogenesis will be locally suppressed or initiated.
Following Stoll et al. [22], we introduce a measure of angiog-
enic activity a deﬁned by
a =
⎧
⎪ ⎪ ⎪ ⎪ ⎪ ⎨
⎪ ⎪ ⎪ ⎪ ⎪ ⎩
  fp
  fa
−1,   fp ≥   fa ,
1 −
  fa
  fp
,   fp <   fa ,
(4)
where a>0 corresponds to angiogenesis being initiated, a =
0 indicates a stable vasculature network, and a<0i m p l i e s
that no angiogenesis is taking place, and vessels could be
regressing.Whileotherformsofthisfunctionforaareviable,
we choose this form due to its symmetry and the apparent
inclusion of the balance between these nondimensionalized
factor concentrations.
A typical angiogenic activity scenario in a solid tumor
maintains angiogenic repression at the tumor core where
heightened levels of angiogenic inhibitors override the eﬀect
of elevated proangiogenic factor production. They also
exhibit angiogenic stimulation near the tumor boundary
where the angiogenic balance leans toward a proangiogenic
tendency. This typically leads to the development of both an
oxygen-deprivedcoreconsistingofhypoxicandnecroticcells
along with a heavily vascularized and rapidly proliferating
outer rim [23].
We use the angiogenic activity measure a to classify the
model output into one of three cases: focal suppression,
global suppression, and global angiogenesis [11]. The typical
focally suppressive behavior described above is characterized
by a transition from negative to positive values of a as we
move from the core to the rim part of the tumor. Global
suppression and angiogenesis are deﬁned by a<0a n d
a>0, respectively, everywhere inside the tumor (i.e., for all
r ∈ [0,R]).
2.3. Interstitial Fluid Pressure. We assume that, as previously
mentioned, Darcy’s law gives the relationship between
interstitial ﬂuid velocity u and interstitial ﬂuid pressure p
in an isotropic and homogeneous tissue: u =− K(dp/dr),
where K is the hydraulic conductivity of the interstitium
(mm2/s/mmHg). The continuity equation for steady-state
incompressible ﬂow is ∇·u = φ(r)w h e r eφ(r) is the ﬂuid4 Computational and Mathematical Methods in Medicine
Table 3: Angiogenic activity resulting from cytotoxic therapy (see
Figure S4).
αt   gt
p = 349 (no treatment)   gt
p = 279 (cytotoxic therapy)
2 Global angiogenesis Global suppression
6 Global angiogenesis Focal suppression
14 Focal suppression Focal suppression
source term (s−1). We assume a continuous distributed
source throughout the tumor given by Starling’s law: φ(r) =
(LpS/V)(pv − p − σ(πv − πi)). Here, the parameters are the
hydraulic permeability of the microvascular wall Lp (mm/
s/mmHg), the surface area of vessel wall per unit volume of
tumor S/V (mm2/mm3), the vascular pressure pv (mmHg),
and the average osmotic reﬂection coeﬃcient for plasma
proteins σ. The plasma and interstitial osmotic pressures are
denoted by πv and πi (mmHg), respectively. Assuming K is
also constant, we substitute Darcy’s law and Starling’s law
into the continuity equation to obtain the model equation
for IFP in a solid tumor [9]
∇2p =−
Lp
K
S
V
 
pv −σ(πv −πi) − p
 
. (5)
Equation (5) can be nondimensionalized by setting   p =
p/pe where pe is the eﬀective pressure pe = pv − σ(πv − πi),
and once again rescaling the radial distance r with the tumor
radius R, gives (in spherical coordinates)
1
  r2
d
d  r
 
  r2d  p
d  r
 
=− α2 
1 −   p
 
,( 6 )
where α = R
 
LpS/(KV). In general, the nondimensional
parameter α may depend on the concentration of growth
factors; for instance, experimental studies [24] have shown
that an increase of VEGF induces approximately a 5-fold
increase in Lp. Here, we assume that α does not change lo-
cally; however, diﬀerent values are chosen for normal (αh),
tumor (αt), and normalized cases [10].
Thepressureparametersforhost(subscripth)andtumor
(subscript t) tissues along with those for tumors whose
vascular structure has been normalized using antiangiogenic
agents are based on Table 3 of Jain et al. [10]; these are
included in Table 2. While their original table has a range for
the vascular pressure pv,w eh a v es e tab a s ev a l u eo fpv = 20
mmHgforalltissues.Thisvalueisclosetothemeanvaluefor
t h er a n g eo fp a r a m e t e r si nb o t hn o r m a la n dt u m o rt i s s u e s .
Similarly, the ranges for S/V are replaced with values near
the mean.
2.4. Solution Method. We assume that the tumor is embed-
ded in normal host tissue (e.g., in an organ) and consider the
followingboundary conditions. Weensuresphericalsymme-
try at the core by imposing dfj/dr|r=0 = 0a n ddp/dr|r=0 = 0
and enforce continuity of factor concentrations and ﬂuxes
at the tumor boundary by setting fj(R−) = fj(R+)a n d
−Dt
j∂fj/∂r+ufj|
r=R− =−Dh
j∂fj/∂r+ufj|
r=R+ alongwithcon-
tinuity of IFP and IFV by setting p(R−) = p(R+)a n d
u(R−)=u(R+), that is, −Kh(dp/dr)|r=R− =− Kt(dp/dr)|r=R+,
where typically Kh = Kt (based on Table 3 from [10]). We
also require that factor concentrations reach steady state as
we move away from the tumor and so impose fj(r) →
gh
j /kh
j(= f s
j ) for large r. Finally, assuming that normal tissue
will eventually drain all excess interstitial ﬂuid we have
p(r) → 0 for large r [10].
The analytical solution for nondimensionalized pressure,
  p, can be obtained by solving (6). This along with the so-
lution for nondimensional IFV,   u = uR/(Ktpe), was derived
by Jain et al. [10] (see Supplement 1 in Supplementry
Material available online at doi: 10.1155/2011/843765). The
radial proﬁle for   p is then used to numerically solve for
the factor concentrations in (3). The corresponding matrix
inversionproblemwasperformedusingasecond-orderﬁnite
diﬀerence scheme in Matlab.
3. Results
Interstitial pressure and velocity proﬁles are obtained from
solving (6); these proﬁles can be viewed in Figures 1(a) and
1(b), respectively. As the parameter αt increases, the pressure
reduction at the tumor rim becomes more drastic, it also
leads to higher IFP inside the tumor. Equivalently, as αt
increases, the interstitial ﬂuid velocity reaches a higher and
sharper peak at the tumor rim. Note that the parameter
choices for αt inside the tumor of 2, 6, and 14 correspond
roughly to parameters associated with normal tissue, nor-
malized tumor tissue, and nonnormalized tumor tissue,
respectively; the choice for αh outside the tumor remains a
constant value of 2 in Figures 1(a) and 1(b) [10].
We solve (3), with the boundary conditions given in
the previous section and the pressure proﬁles obtained
from solving (6), to determine AGF concentrations and
subsequently the imbalance factor in (4). First, we compare
the results of our model with those of the model without
convection [11]; the only diﬀerence between the curves
corresponding to no convection in Figure 2(a) and the
original results of [11] is that we consider a tumor radius
of 4mm (up from 2.5mm) in order to remain consistent
with the parameter estimates from [10] that are used for
the pressure model. For our model with convection, the
angiogenic activity still reaches a maximum at the tumor
boundary, and the region of angiogenic suppression persists
at the tumor core. However, we now observe a higher peak
of angiogenic tendency at the rim and a larger area of angio-
genic stimulation, see Figure 2(b). This is due to the larger
diﬀerence between the proangiogenic and antiangiogenic
growth factor concentrations near the boundary, a result of
these factors being pushed out of the tumor core into the
surrounding normal tissue, see Figure 2(a).H o w e v e r ,a sw e
will see, the transition from a system without convection to a
system with convection is not straightforward.
By changing the values of αt, we can see the eﬀect of
varying only the contribution of the pressure proﬁle on the
model. This can be achieved by modifying Lp, S/V,o rR.
However, we wish to consider a ﬁxed tumor radius and
surface to volume ratio, so we will consider changes in αt toComputational and Mathematical Methods in Medicine 5
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Figure 1: Relative pressure and velocity proﬁles when αh = 2.
Relative IFP is   p = p/pe and relative IFV is   u = uR/(Ktpe).
Legend entries correspond to approximate αt values for normal
tissue, normalized, and nonnormalized tumor tissues, respectively.
The tumor boundary is at   r = 1.
correspond to changes in the values of Lp only. Note that we
cannotanalyzethecontributionofIFPalonebymodifying K
since this would alsochange the value of the nondimensional
convection parameter in (3). Similarly, we can look at the
contribution of the nondimensional convection parameter
alone by modifying pe. Finally, we will consider the eﬀect of
changingthehydraulicconductivityK whichsimultaneously
decreases αt and increases   Kj aﬀecting the pressure proﬁle
and the rate of convection.
˜ r
˜
f
j
1
2
3
4
5
6
0 0.5 1 1.5 2
No convection
Convection
(a)
˜ r
a
−0.1
0
0.1
0.2
0.3
0.4
0 0.5 1 1.5 2
No convection
Convection
(b)
Figure 2: Comparing nondimensionalized proangiogenic (solid)
and antiangiogenic (dashed) growth factor concentrations
(Figure 2(a)) and angiogenic activity (Figure 2(b))f o rt h em o d e l
without convection (u = 0) and with convection (αt = 14, αh = 2).
With the addition of convection, the area of angiogenic stimulation
is larger and more pronounced.
We consider ﬁrst the eﬀects of varying only the pressure
parameter αt (for ﬁxed αh = 2), which, as stated above,
we will assume is achieved by changing Lp, leaving the rest
of the parameters ﬁxed as in Table 2.A sc a nb es e e ni n
Figures 3(a) and 3(b), the results suggest that altering the
pressure parameter leads to diﬀerent angiogenic behavior
in the tumor. Indeed, the region of angiogenic suppression
(a<0) at the core is not conserved for all values of αt
between the cases of negligible convection (αt ≈ 0) and
nonnormalized tumor tissue (αt = 14). Thus, the behavior
is more complicated than that observed by modifying6 Computational and Mathematical Methods in Medicine
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Figure 3: Eﬀect of varying the vascular hydraulic permeability,
Lp (mm/s/mmHg), in the tumor tissue on AGF concentrations
(Figure 3(a)) and angiogenic activity (Figure 3(b)). The values of
αt = 2, 6, 14 correspond to Lp = 3.6 × 10−7,3 .7 × 10
−6,1 .86 ×
10
−5 mm/s/mm Hg. The parameter for host tissue was ﬁxed at
αh = 2. This changes the shape of the resulting pressure proﬁle and
thus the interstitial ﬂuid velocity.
the convection parameter via pe or both pressure and con-
vection parameters viaK (see Figures 4 and 5 and Discussion
below). For values of αt close to zero, there is a region of
angiogenic suppression (a<0) at the core and stimulation
(a>0) at the rim (similar to the “no convection”
case in Figure 2(b)). For midrange values of αt the tumor
can experience global angiogenesis (i.e., a>0f o ra l l
˜ r
0 0.5 1 1.5 2
˜
f
j
1
2
3
4
5
6
˜ r
0 0.5 1 1.5 2
−0.1
0
0.1
0.2
0.3
0.4
0.5
a
pe = 5
pe = 15
pe = 35
Figure 4: The eﬀect of varying pe (mmHg) on AGF concentrations
(inset) and angiogenic activity for ﬁxed Lp = 1.86×10−5 mm/s/mm
Hg. This alters the value of the convection parameters   Kj.
r ∈ [0,R]). That is, instead of the proangiogenic and
antiangiogenic concentrations balancing inside the tumor,
the antiangiogenic factor concentration lies entirely below
that of the proangiogenic factor concentration. Considering
αt = 2, this assumes that the tumor tissue has the same value
of Lp as normal tissue. Indeed, the angiogenic activity in this
case remains constant inside the tumor due to a consistent
diﬀerence between the two factor concentrations leading to
global angiogenesis. For the parameters corresponding to
normalized tumor tissue (αt = 6), we see an intermediate
behaviorwhereglobalangiogenesisoccurs,buttheactivityat
thecoreismuchlowerthanatthetumorrim.Forhighvalues
of αt (e.g., αt = 14), the core once again becomes a region
of suppression but with higher levels of angiogenic activity
occurring close to the tumor rim as previously observed
in the “convection” case in Figure 2(b). While diﬀerent
angiogenic proﬁles are obtained, it remains true that the
angiogenic activity at the tumor rim increases with αt.
As expected, ﬁxing αt = 14 and increasing pe, thereby
increasing the convection of factors leads to higher con-
centrations outside the tumor (see Figure 4)a n dl a r g e r
concentration diﬀerences at the rim. This coincides with an
increase of angiogenic activity at the tumor rim. For the
parameters considered and a reasonable range of pe, the
tumorexhibitsonlyfocalsuppression.Otheractivitiescanbe
achieved but require a modiﬁcation of the AGF parameters
(see the sensitivity analysis in Figures S1–S3).
Finally,we considervarying K,anincreasein thisparam-
eter value leads to decreased αt and αh along with increased
values of the convection parameters   Kj. This essentially
compounds the eﬀects observed in Figures 3(a), 3(b) and
4 leading to elevated levels of angiogenesis inside the tumor
(from decreasing αt) and at the tumor rim (from increasing
pe); refer to Figure 5.Computational and Mathematical Methods in Medicine 7
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Figure 5: The eﬀect of increasing K (mm2/s/mmHg) on AGF
concentrations(inset)andangiogenicactivityforﬁxedLp = 1.86 ×
10−5 mm/s/mmHg and pe = 10.9mm Hg.This simultaneously
decreases αt and increases   Kj leading to altered IFP and elevated
convective transport.
Following Ramanujan et al. [11], we performed a sen-
sitivity analysis on AGF production; see the Supplementary
Figures S1–S3. We generalize their results by ﬁxing one of
the parameters of interest (αt, pe,a n dK) and analyze results
o v e ral a r g er a n g eo ft u m o rp r o d u c t i o nv a l u e s(   gt
p and   gt
a).
Focal suppression occurs between lines of the same color,
global suppression occurs above this region (high   gt
a low
  gt
p), and global angiogenesis occurs above (low   gt
a,h i g h  gt
p).
The results indicate that focal suppression is observed only
for a narrow sliver of the parameter space. This is realistic
since one would assume that the behavior is sensitive to the
balance of these factors’ production rates. As expected, the
behavior is not as sensitive to varying the host production
parameters as it is to tumor production (results are not
shown).
Figure S1 shows how this sensitivity changes when vary-
ing αt.A sαt increases, the region of focal suppression widens
from a very narrow region to encompass more of the
parameter space above and below this region. For diﬀerent
values of pe, we notice little movement in the boundary
between focal suppression and global angiogenesis while the
boundary between focal suppression and global suppression
increases with pe (see Figure S2). Finally, for K,w es e ea
combination of these eﬀects; the region where focal sup-
pression and peripheral stimulation occur is widening and
drifting towards the top left corner of Figure S3 (high   gt
a,
low   gt
p). Parameter values that correspond to focal suppres-
sion switch to values corresponding to globally angiogenic
behavior when the convection term is added. Also shown
in these graphs are the precise points in parameter space
corresponding to the tumor production values   gt
p = 349 and
  gt
p = 279 (see Section 4).
4. Discussion
We have presented a mathematical model to study the eﬀects
of interstitial convection on proangiogenic and antiangio-
genic factor concentrations in tumor and surrounding host
tissue,andfromthisdeterminedtheoverallangiogenicactiv-
ity of the tumor. The resulting AGF concentration proﬁles
agree qualitatively with experimental observations that show
the highest concentrations in the core of the tumor, decreas-
ing as one approaches the tumor rim [4]. Also, the resulting
angiogenic behaviors, including suppression at the tumor
core and maximal angiogenic stimulation near the tumor
rim, correspond with experimental observations such as
tumorperfusion[25].Theimbalancebetweenproangiogenic
andantiangiogenicfactorsprovidesanempiricalexplanation
forobservedangiogenicactivityandcouldbecorrelatedwith
resulting tumor necrosis or growth. While the precise eﬀects
of IFP and factor convection on the angiogenic activity of
tumors have not been experimentally veriﬁed, our results
indicate that an IFP gradient could signiﬁcantly inﬂuence
suppression and stimulation of angiogenesis in a tumor.
While not explicitly included, the eﬀectof antiangiogenic
treatments can be ascertained in this model since it has
been shown that the value of αt decreases when the
vasculature is normalized due to the application of, for
instance, anti-VEGFR-2 [10]. The value of αt can decrease
through any combination of decreasing S/V, Lp,o rR,
all of which could occur as a result of antiangiogenic
therapy. S/V decreases as blood vessels are destroyed and/or
remodeled due to the administration of an antiangiogenic
drug (in this case, there is less area of vessel wall per unit
of tumor volume). The radius R decreases indirectly; as
tumor vessels regress, tumor cells are deprived of oxygen
and consequently become hypoxic or necrotic. Moreover,
the vessel permeability Lp could decrease due to judicious
application of antiangiogenic agents (vessel normalization,
[2] ) .T h ep r e s s u r ep a r a m e t e rαt could also be decreased
by increasing the hydraulic conductivity K,a ne ﬀect that
would be somewhat counterbalanced by the corresponding
increase in the convection parameter (refer to Figure 5).
However, K could be increased by administering enzymes
that degrade the extracellular matrix (ECM), which sub-
sequently decreases the ﬂow resistance in the interstitium
[21]. Overall, strategies that lead to the reduction of the
parameter αt result in decreased IFP, which inﬂuences tumor
angiogenesis activity. As shown in Figure 3(b) and discussed
in Section 3, the changes in the interstitlal ﬂuid velocity
from decreasing αt reduces the angiogenic activity at the
rim and produces a more constant level of angiogenic
activity inside the tumor. On the other hand, one could
also consider the administration of antiangiogenic agents
by decreasing the concentration of proangiogenic factors
through an increase of their degradation (or deactivation)
constant(seeFigure S5).Thisincreaseindeactivationshould
take into account that most antiangiogenic treatments only
aﬀect a single factor or a family of growth factors.
One can consider the eﬀect of cytotoxic therapies by
noting that the application of either chemotherapy or radio-
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proangiogenicfactorproduction(Figure S4);thisisachieved
byloweringtheparameter   gt
p.Weconsideredthereductionof
this production rate and the movement through parameter
space is shown in the sensitivity diagrams (Figures S1–S3).
In Figure S4, we can observe that the resulting angiogenic
behavior depends on the value of αt as summarized in
Table 3. The eﬀect of cytotoxic therapies either on tumor
cells or blood vessels could also reduce the pressure due to
increased interstitial space; this could be included in our
model by, for instance, increasing K (Figure 5). The eﬀects
of cytotoxic treatments could also be included by reducing
the tumor radius R. Combinations of antiangiogenic therapy
and chemotherapy could be considered by performing the
aforementioned parameter changes simultaneously; these
changes compound the eﬀects leading to even further
reduced angiogenic tendency.
Decreasing the IFP prior to or simultaneously with other
therapies is an important concern in cancer treatment since
the ﬂow of interstitial ﬂuid out of the tumor prevents drugs
from penetrating the tumor bulk. While the various eﬀects
of antiangiogenic treatments (decreasing S/V, Lp,o rR)o r
ECM-degrading enzymes (increasing K)a l lr e d u c eαt and
hencepressure,thereareotherindependentmechanismsthat
could also elicit reductions in pressure. For instance, reduc-
ing pe would reduce IFP. This could be achieved by reducing
the vascular pressure pv, which can be readily accomplished
by decreasing the resistance of blood. Clinically, decreasing
the viscosity of the blood or normalizing the tumor vascu-
lature would accomplish the goal of less resistance [21]. The
eﬀects of changing pe are shown in Figure 4 as decreasing the
eﬀective pressure leads to diminishing levels of angiogenic
activity at the rim.
By taking into consideration the diﬀerent angiogenic
behaviors exhibited by modifying any of the key parameters
involved in the pressure model, we can establish an alternate
(or more likely, complementary) mechanism for these chan-
ges. Whereas it was previously hypothesized [11] that the
production, degradation, and diﬀusion of the AGFs were
primarily responsible for the overall angiogenic behavior, we
have exhibited that changes in the tumor tissue physiology
couldalsoelicitthesechanges.Theinterplaybetweenthetwo
groups of parameters, those related to AGF properties that
determine AGF concentrations and those corresponding
to the tumor physiology that determine interstitial ﬂuid
pressure, should be further investigated with more detailed
modeling and experimental work. We emphasize that it
was never the goal of this work to quantitatively predict
concentrations of speciﬁc AGFs or to model the process
of angiogenesis but rather to emphasize the importance of
tumor tissue properties and macromolecule convection on
angiogenic behavior.
One should note that there are limitations to our mathe-
matical model, many of which have been mentioned during
the model development. These include the existence of two
distinct groups of AGFs, the speciﬁc functional form of our
angiogenic activity measure and the distributed ﬂuid source
terms. Most prominent among these various assumptions
are those of spherical symmetry and homogeneity of tissues
and environment [11]. The other main limitation is the
assumption of constant parameter values both inside the
tumor and in the host tissue, or even the constant values
assumed across this boundary. These assumptions make
the modeling and computation tractable especially since
physiological parameters as functions of radial distance are
uncommon in the literature. However, our computational
approach can readily be extended to include aspects of the
heterogeneous tumor microenvironment upon availability
of relevant experimental data. Finally, we propose that an
experimental study measuring both interstitial ﬂuid pressure
and quantities associated with AGF concentrations or angio-
genicactivity(suchasvesseldensityorperfusion)wouldhelp
to validate our qualitative model predictions.
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